Publications by authors named "Manuel Constenla"

Claim this Profile
C
Clinical outcomes and subsequent therapy in patients with platinum-sensitive recurrent ovarian cancer deriving long-term benefit from maintenance niraparib: a subgroup analysis of the GEICO-88R study.
Juan F Cueva, Isabel Palacio, Cristina Churruca, Ana Herrero, Beatriz Pardo, Manuel Constenla

Int J Gynecol Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme.
Juan F Cueva, Isabel Palacio, Cristina Churruca, Ana Herrero, Beatriz Pardo, Manuel Constenla

Eur J Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain - A GEICO study.
Alfonso Yubero, Aranzazu Barquín, Purificación Estévez, Bella Pajares, Luisa Sánchez, Manuel Constenla

BMC Cancer· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous adverse events in patients receiving anticancer therapy in a tertiary hospital setting: the old and the new.
Hae-Jin Suh, Ángeles Flórez, Víctor Sacristán, Ángeles Rodríguez Martinez, Francisca Fernández, Manuel Constenla

Int J Dermatol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Working towards a consensus on the oncological approach of breakthrough pain: a Delphi survey of Spanish experts.
Carlos Camps Herrero, Antonio Antón Torres, Juan Jesús Cruz-Hernández, Alfredo Carrato, Manuel Constenla

J Pain Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Study of Survival following Videothoracoscopic Lobectomy Procedures for Lung Cancer: Single- versus Multiple-port Approaches.
José M Borro, Francisco Regueiro, Sonia Pértega, Manuel Constenla, Salvador Pita

Arch Bronconeumol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standard versus continuous administration of capecitabine in metastatic breast cancer (GEICAM/2009-05): a randomized, noninferiority phase II trial with a pharmacogenetic analysis.
Miguel Martín, Noelia Martínez, Manuel Ramos, Lourdes Calvo, Ana Lluch, Manuel Constenla

Oncologist· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Darbepoetin alfa administered once every three weeks for the treatment of anemia in elderly patients with non-myeloid tumors receiving chemotherapy.
Gaspar Esquerdo, Mercedes Doménech, Pilar López, Carme Pedro, Kenny Villadiego, Manuel Constenla

Tumori· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cisplatin plus oral vinorelbine as first-line treatment for advanced non-small-cell lung cancer: a prospective study confirming that the day-8 hemogram is unnecessary.
M Provencio, A Sánchez, A Artal, J M Sánchez Torres, Ramón García Gómez, Manuel Constenla

Clin Transl Oncol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients: data from the INC-EU Prospective Observational European Neutropenia Study.
Matthias Schwenkglenks, Ruth Pettengell, Christian Jackisch, Robert Paridaens, Manuel Constenla

Support Care Cancer· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cetuximab given every 2 weeks plus irinotecan is an active and safe option for previously treated patients with metastatic colorectal cancer.
José-María Roca, Vicente Alonso, Carles Pericay, Pilar Escudero, Antonieta Salud, Manuel Constenla

Chemotherapy· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multivariate analysis of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma: data from the INC-EU Prospective Observational European Neutropenia Study.
Ruth Pettengell, André Bosly, Thomas D Szucs, Christian Jackisch, Robert Leonard, Manuel Constenla

Br J Haematol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutropenia occurrence and predictors of reduced chemotherapy delivery: results from the INC-EU prospective observational European neutropenia study.
Ruth Pettengell, Matthias Schwenkglenks, Robert Leonard, André Bosly, Robert Paridaens, Manuel Constenla

Support Care Cancer· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High circulating HER2 extracellular domain levels correlate with reduced efficacy of an aromatase inhibitor in hormone receptor-positive metastatic breast cancer: a confirmatory prospective study.
Ramon Colomer, Antonio Llombart-Cussac, Belen Lloveras, Manuel Ramos, Jose I Mayordomo, Manuel Constenla

Cancer· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study.
Joaquín Casal, Margarita Amenedo, José Ramón Mel, Luis Miguel Antón, Rubén Rodríguez-López, Manuel Constenla

Cancer Chemother Pharmacol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group.
Jaffer A Ajani, Vladimir M Moiseyenko, Sergei Tjulandin, Alejandro Majlis, Manuel Constenla

J Clin Oncol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: the V-325 Study Group.
Jaffer A Ajani, Vladimir M Moiseyenko, Sergei Tjulandin, Alejandro Majlis, Manuel Constenla

J Clin Oncol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.
Eric Van Cutsem, Vladimir M Moiseyenko, Sergei Tjulandin, Alejandro Majlis, Manuel Constenla

J Clin Oncol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutropenic event risk and impaired chemotherapy delivery in six European audits of breast cancer treatment.
Matthias Schwenkglenks, Christian Jackisch, Manuel Constenla, Joseph N Kerger, Robert Paridaens

Support Care Cancer· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-HT3 receptor antagonists for prevention of late acute-onset emesis.
Manuel Constenla

Ann Pharmacother· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant use of anastrozole in breast cancer.
Jack Cuzick, Aman Buzdar, Michael Baum, Raffaele Bianco, Robert Coleman, Manuel Constenla

J Clin Oncol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel, 5-fluorouracil, and leucovorin as treatment for advanced gastric cancer: results of a phase II study.
Manuel Constenla, Ramon Garcia-Arroyo, Isabel Lorenzo, Nancy Carrete, Begoña Campos

Gastric Cancer· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response predicting factors to recombinant human erythropoietin in cancer patients undergoing platinum-based chemotherapy.
Manolo González-Barón, Amdio Ordóñez, Rosa Franquesa, Manuel Constenla, Joaquin Montalar

Cancer· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis